Intestinal peristalsis is a dynamic physiologic process influenced by dietary and microbial changes. It is tightly regulated by complex cellular interactions; however, our understanding of these controls is incomplete. A distinct population of macrophages is distributed in the intestinal muscularis externa. We demonstrate that, in the steady state, muscularis macrophages regulate peristaltic activity of the colon. They change the pattern of smooth muscle contractions by secreting bone morphogenetic protein 2 (BMP2), which activates BMP receptor (BMPR) expressed by enteric neurons. Enteric neurons, in turn, secrete colony stimulatory factor 1 (CSF1), a growth factor required for macrophage development. Finally, stimuli from microbial commensals regulate BMP2 expression by macrophages and CSF1 expression by enteric neurons. Our findings identify a plastic, microbiotadriven crosstalk between muscularis macrophages and enteric neurons that controls gastrointestinal motility.
INTRODUCTION
Peristaltic movements of the gut are essential to propel ingested material through the gastrointestinal (GI) tract. These movements are generated by coordinated contractions and relaxations of the circular and longitudinal smooth muscles that form the muscularis externa ( Figure 1A ). The pattern and frequency of peristaltic contractions are locally regulated by the enteric nervous system (ENS) (Furness, 2012) and pacemaker interstitial cells of Cajal (ICCs) (Huizinga et al., 1995; Rumessen and Vanderwinden, 2003) .
Mononuclear phagocytes, which include dendritic cells (DCs) and macrophages, form a heterogeneous group of myeloid cells that are found in most tissues. Their common functions are to maintain tissue homeostasis through scavenging and participation in immune responses (Hashimoto et al., 2011b) . A network of MHCII + macrophages exists in the intestinal muscularis in both mice and humans (Mikkelsen and Rumessen, 1992; Mikkelsen et al., 1985) . This network extends from the stomach to the distal colon (Mikkelsen, 2010) . Within the muscularis, these macrophages mainly accumulate in layers, between the serosa and the longitudinal muscle, between longitudinal and circular muscles, and between the outer and inner circular muscles (Mikkelsen, 2010) . In addition to their phagocytic properties (Mikkelsen et al., 1985) , muscularis macrophages (MMs) are potent antigen-presenting cells and are sometimes referred to as DCs (Flores-Langarica et al., 2005) .
The functions of MMs are far less defined compared to their mucosal counterparts. Some studies have implicated MMs in the pathogenesis of postoperative ileus, a transient inflammatory condition of the GI tract that results in intestinal paralysis (Mikkelsen, 2010) . In surgically manipulated areas of the gut, the release of inflammatory mediators by activated MMs is thought to impair GI motility by affecting smooth muscle contractility directly, as well as through the recruitment of additional inflammatory cells (Boeckxstaens and de Jonge, 2009; Wehner et al., 2007) . Whether MMs play a role in regulating constitutive GI physiology, however, has never been determined. Intrigued by the distinctive distribution of these cells and driven by the idea that macrophages are essential regulators of tissue homeostasis (Chow et al., 2011 (Chow et al., , 2013 Wynn et al., 2013) , we hypothesized that MMs may provide trophic support to smooth muscle cells and, through that support, regulate constitutive GI motility.
To test our hypothesis, we developed a model for the selective transient depletion of MMs. We then demonstrated that MMs Figure S1 .
regulate intestinal peristalsis at steady state and identified a specific factor, BMP2, that is secreted by MMs and regulates GI motility through a direct action, not on smooth muscle, but on enteric neurons. Our work revealed that MMs and enteric neurons communicate with each other. MMs support enteric neurons by providing BMP2, whereas neurons promote MM homeostasis through production of the macrophagespecific growth factor CSF1. Finally, we have found that signals from the intestinal microbiota are able to influence the crosstalk between MMs and enteric neurons and alter GI motility.
RESULTS

MM Development Requires CSF1 Receptor Signaling
The intestine is a complex layered structure that includes the mucosa, submucosa, and muscularis externa ( Figure 1A (Bogunovic et al., 2009 (Bogunovic et al., , 2012 . Very little is known about the phenotype and function of MMs, mainly because these cells are difficult to isolate from intestinal tissue. A technique for separating the intestinal muscularis externa from the overlying mucosa and submucosa allowed us to perform a detailed analysis of MMs using wholemount tissue preparations and single-cell suspensions (Bogunovic et al., 2009 (Bogunovic et al., 2009 ) that express high levels of CX 3 CR1 (Figures 1A-1C) . The MM population resembles the CD103 À CD11b + CX 3 CR1 + macrophages, which are found in the intestinal lamina propria (LP) (Bogunovic et al., 2009) . In a suspension of intestinal cells, MMs can easily be distinguished from CD11c hi LP phagocytes by the lower expression of CD11c and higher expression of MHCII (Bogunovic et al., 2009; Figure S1A available online) . FLT3 and CSF1 (also known as macrophage colony stimulatory factor [M-CSF]) receptor (CSF1R) are two key growth factor receptors that control mononuclear phagocyte development (Hashimoto et al., 2011b) . We previously demonstrated that CD103
À
CD11b
+ LP macrophages require CSF1R signaling for their homeostasis and are reduced in Csf1r À/À mice (Bogunovic et al., 2009) . The phenotypic similarity between MMs and CD103 À CD11b + LP macrophages led us to investigate the role of CSF1R in MM development. We found that MMs express Csf1r ( Figure 1D ) and must absolutely be dependent on CSF1R signaling because Csf1r À/À mice lack these cells ( Figures 1E-1G ). Moreover, Csf1r À/À bone marrow (BM) progenitors fail to develop into MMs when transplanted into lethally irradiated recipients ( Figure 1H ). To study the function of MMs, we developed a model in which homeostatic properties are used to selectively deplete MMs. We found that MMs are more dependent on CSF1R signaling than LP phagocytes ( Figures 1G and 1H ), which provided us with a strategy to selectively deplete one population without affecting the other. Because CSF1R expression in the gut is restricted to MMs and mucosal macrophages (Figures S1B-S1D; small bowel (SB) mucosa and submucosa [data not shown]), a single intraperitoneal (i.p.) injection of a low dose of a blocking anti-CSF1R monoclonal antibody (Sudo et al., 1995 ) (aCSF1R mAb) was able to deplete at least 80% MMs (Figures 2A-2E , S2A, and S2B) without depleting LP phagocytes ( Figures 2C, 2D , and S2B) or stromal cells (data not shown). MM numbers were reduced 24 hr after the antibody injection and returned to normal 7 days later (data not shown). No differences in CSF1R levels in MMs or MM depletion efficiency were observed between the SB and large bowel (LB) (Figures 2A-2E , S1C, S2A, and S2B). This depletion was considered to be noninflammatory because there was no lymphocyte ( Figures 2F, S2C , and S2D), neutrophil, or monocyte (data not shown) recruitment in either the muscularis or mucosa. Injection of aCSF1R mAb also did not increase apoptotic cell numbers in the gut ( Figure S2E ). Taken together, these findings identified CSF1R as essential for MM development and established blocking CSF1R in vivo as a model for the transient depletion of these cells.
MMs Regulate GI Motility at Steady State
In the isolated intestine, one can elicit the peristaltic reflex by providing a distending force to the intestinal wall (Frigo and Lecchini, 1970) . To determine whether conditional depletion of MMs affects the peristaltic reflex, we developed an ex vivo method to record peristaltic contractions in response to stepwise distension of colonic rings ( Figure 3A ). Repeated applications of increasing stretch resulted in an immediate contraction of the rings followed by gradual relaxation, creating a ladder-like pattern of recordings. Augmented stretching generated additional high-amplitude contractions (further called ''stretchinduced contractions''), which gradually increased in amplitude and frequency ( Figure 3B ). In MM-depleted colonic rings, stretch-induced contractions were evoked at shorter durations of stretch, were more rapid, and had a significantly higher frequency ( Figures 3B and 3C) ; thus the root-mean-square (rms) of the signal was increased ( Figures 3C and 3D ). Despite the evident colonic hyperreactivity ex vivo, colonic transit time, measured in vivo by bead expulsion assay, was increased after MM depletion, probably because the muscle contractions were poorly coordinated and inefficient ( Figure 3E ). Among other parameters of GI motility, gastric emptying was accelerated, whereas transit from the stomach along the SB and total intestinal transit time were not significantly changed ( Figures S2F-S2H ). This would occur if accelerated gastric emptying and delayed SB and LB motility cancel each other out, thus suggesting that the motility of the entire GI tract is affected by MM depletion.
To further confirm the role of MMs in regulating GI motility, we generated syngeneic BM chimeric animals with Csf1r À/À hematopoietic progenitors (from fetal liver). Some Csf1r À/À BM chimeric mice clearly developed a delay of colonic transit time ( Figure S2I) ; however, poor engraftment of Csf1r À/À BM and the consequent low survival rate of these chimeric animals did not permit us to obtain enough animals for statistical comparisons. In summary, the observation that removal of MMs results in dysmotility indicates that MMs contribute to the physiological regulation of GI motility.
MMs Regulate Intestinal Peristalsis through the Production of BMP2
These findings raised the question: by what mechanisms do MMs affect GI motility? We tested the initial hypothesis that MMs secrete a soluble factor that alters smooth muscle contractility. To identify the gene that encodes a putative target protein, we carried out a murine gene expression microarray on different purified intestinal phagocyte subsets (Bogunovic et al., 2009 (Bogunovic et al., , 2012 and did a comparative data analysis to select genes that are highly expressed by MMs but not by related CD103 -CD11b + LP macrophages. Bone morphogenetic protein 2 (BMP2) was identified as the only nonimmune gene among the ''top four'' most highly expressed genes that also encoded a soluble factor (Cd163, F13a1, Clec4e, and Bmp2; Figures 4A and 4B) . No other BMP family members were expressed by either intestinal phagocyte subset (Figures 4C and results not shown). BMPs are a group of secreted proteins in the transforming growth factor b (TGF-b) superfamily that are thought to mainly control organ development (Hogan, 1996) . Bmp2 -/-mice are embryonically lethal (Zhang and Bradley, 1996) and Bmp2 +/-mice are susceptible to hypoxic pulmonary hypertension characterized by sustained high pressure in pulmonary arteries due to increased vascular reactivity and structural remodeling (Anderson et al., 2010) . BMP2 is highly expressed in the fetal (but not adult) gut, and BMP receptor (BMPR) signaling has been implicated in enteric smooth muscle and neuronal differentiation (Chalazonitis et al., 2004 (Chalazonitis et al., , 2008 Faure et al., 2007b; Fu et al., 2006; Goldstein et al., 2005) . Using quantitative PCR (qPCR), we confirmed that Bmp2 is expressed in MMs but is absent in purified muscularis lymphocytes ( Figure 4D ). In situ BMP2 protein expression was also restricted to MHCII + MMs ( Figure 4E ). To examine whether BMP2 plays a role in regulating colonic motility, we compared the patterns of stretch-induced contraction of colonic rings in mice treated in vivo with the inhibitor of BMPR signaling, dorsomorphin (Yu et al., 2008) , and mice treated only with vehicle. Treatment with dorsomorphin elicited a pattern of contractile hyperreactivity similar to that seen in colonic rings from MM-depleted mice (Figures 4F and S3A) . To confirm that the pattern resulted from deficient BMPR signaling, we carried out a ''rescue'' experiment in which increasing concentrations of exogenous BMP2 were added to the colonic rings from MMdepleted mice. BMP2 was added during recording of stretchinduced contractions at a previously determined ''optimal'' 2.75 mm stretch distance. BMP2 reduced stretch-induced contractions in a concentration-dependent manner ( Figures 4G-4I ). There were no changes in contractility when the same amounts of BMP2 were added to colonic rings in which MMs had not been depleted ( Figure 4G ). Consistent with our in vitro data, BMP2 injection partially accelerated the colonic transit time ( Figure 4J ). Taken together, our data support the idea that MM secretion of BMP2 regulates colonic contractility.
MMs Activate Enteric Neurons that Express BMPR
We next sought to identify the cells targeted by MM-derived BMP2. The force with which smooth muscles contract in response to exogenous stimuli (stretch or KCl) was unaffected after MM depletion ( Figures S3B and S3C ). CKit + ICC and bIIITubulin + ENS networks do not overlap ( Figure S4A ). Both ICC and ENS networks remained intact after MP depletion ( Figures  5C and S3D ), indicating that acute MM depletion does not anatomically disrupt ICCs or the ENS. The numbers of epithelial serotonin + enteroendocrine cells, which activate peristaltic reflexes in response to luminal signals Crema, 1959a, 1959b; Heredia et al., 2013) , were also unaffected by injection of aCSF1R mAb ( Figures S3E and S3F) . Additionally, intestinal epithelial permeability remained unaffected even after treatment with maximal doses of aCSF1R mAb (Figures S3G and S3H) . We assessed the anatomical interaction between MMs and enteric neurons and found that the vast majority of MMs were positioned along nerve fibers, often forming close appositions ( Figure 5A ). BMP2 signals through the oligomerization of type I and type II serine kinases (BMPRIa and BMPRII, respectively), which form BMPR (Kirsch et al., 2000) . We found that BMPRII was selectively expressed by neurons marked by (Derynck and Zhang, 2003) . Treatment of cultured primary enteric neurons, which express BmprIa and BmprII, but not BmprIb and Bmp2 ( Figure S4D ), with recombinant BMP2 resulted in the rapid accumulation of pSMAD1/5/8 complex in the neuronal nuclei ( Figure S4E ). Moreover, the nuclei of the vast majority of BMPRII + enteric neurons in vivo were positive for pSMAD1/5/8, demonstrating that activation through BMPR was constitutively occurring (Figures 5C and 5D) . In contrast, MM depletion resulted in the disappearance of pSMAD1/5/8 from nuclei in most of the enteric neurons in vivo, consistent with the key contribution of MMs to BMPR signaling ( Figures 5C and 5D) . Incubation of the muscularis layer devoid of MMs with exogenous BMP2 restored the numbers of enteric neurons with pSMAD1/5/8-immunoreactive nuclei to nearly normal levels ( Figures 5C and 5D ). These data imply that MMs provide continuous signaling to neurons through the secretion of BMP2, which activates the BMPR that they express.
Enteric Neurons Produce the Macrophage Growth Factor CSF1 CSF1 and interleukin-34 (IL-34) are two alternative ligands that activate CSF1R Yeung et al., 1987) and each of these cytokines have been implicated in the development of different macrophage populations (Greter et al., 2012; Hashimoto et al., 2011b; Wang et al., 2012) . MMs do not express either Csf1 ( Figure 1A ) or Il34 (data not shown), suggesting that CSF1 and IL-34 must be produced by a different cell population, possibly stromal cells. CSF1 and Il-34 are alternatively expressed by distinct subtypes of mature neurons in the postnatal brain (Nandi et al., 2012) . We thus asked whether there is additional crosstalk between enteric neurons and MMs in which enteric neurons provide CSF1R ligands to MMs. We found that enteric neurons express Csf1, but not Il34 in culture ( Figures  6A and 6B) , and are the main source of CSF1 protein in the muscularis ( Figure 6C ). As expected, and consistent with an earlier report (Mikkelsen and Thuneberg, 1999) , CSF1-deficient Csf1 op/op mice almost completely lack MMs (Figures 6D-6F ).
These results suggest that enteric neurons likely play a key role in the maintenance of MM homeostasis. Osteoclast-deficiency-related bone defects in Csf1 op/op mice, including toothlessness (Wiktor-Jedrzejczak et al., 1991) and their significantly smaller size ( Figure S5A ), prevented us from analyzing GI motility in these animals. However, we observed that, despite the smaller size of both the length and diameter of the Csf1 op/op intestine (length of SB: 80% of WT [Huynh et al., 2009] ; length of LB: 80% of WT), the cecum of these animals was larger than of WT mice ( Figure S5B) S5C ). We also observed a significant increase in the total numbers of enteric neurons together with a less organized architecture of the ENS in Csf1 op/op mice ( Figures 6H and 6I ), suggesting the importance of MMs in ENS development. This observation is similar to previous findings regarding the ENS of NSE-noggin mice, which overexpress the endogenous BMP inhibitor noggin under the control of the neuron-specific enolase (NSE) promoter (Chalazonitis et al., 2004; Chalazonitis et al., 2008) .
Luminal Microbiota Regulate Macrophage-Neuronal Crosstalk Luminal microbiota appear to be essential for the normal regulation of intestinal motility, and severe dysmotility has been described in germ-free rodents (Abrams and Bishop, 1967; Gustafsson et al., 1970) and in Tlr4 -/-and Myd88 -/-mice (Anitha et al., 2012). The mechanisms by which commensals regulate intestinal motility are poorly understood and may involve abnormalities of many different cell types. Slowing of GI motility in germ-free, antibiotic-treated Tlr4 -/-and Myd88 -/-mice is accompanied by an alteration in the phenotypic diversity of enteric neurons with reduced numbers of nitrergic neurons (Anitha et al., 2012) . Whether MMs contribute to these regulatory processes is not known. Similarly to published reports (Abrams and Bishop, 1967; Anitha et al., 2012; Gustafsson et al., 1970) , we found that GI motility is grossly disturbed in mice treated with broad-spectrum antibiotics ( Figures 7A,  S6A , and S6B). Megacolon also occurs in these animals (Figure S7E) , and thus a bead expulsion assay was not valuable for measuring colonic motility. Upon performing ex vivo analyses, we found that colonic rings from antibiotic-treated mice displayed a pattern of contractile hyperreactivity similar to that seen in colonic rings from MM-depleted or dorsomorphin-treated mice ( Figures 7B and S6C) . Strikingly, we found that antibiotic-treated mice expressed significantly less Bmp2 compared with control mice (Figure 7C ), suggesting that microbial commensals influence the interaction between MMs and enteric neurons. Consistently, the numbers of pSMAD1/5/8 + enteric neurons were significantly reduced in antibiotic-treated mice compared with littermate controls that received only water ( Figures 7D and S6D ). We then questioned whether commensal signals can also regulate CSF1 production by enteric neurons. We found that addition of lipopolysaccharide (LPS) to cultured primary enteric neurons increased their expression of Csf1 ( Figure 7E ), whereas culture of primary enteric neurons in the presence of exogenous BMP2 did not affect Csf1 expression levels (data not shown). Consistently, antibiotic treatment in vivo reduced Csf1 expression in the colonic muscularis ( Figure 7F ), although the kinetics of Csf1 reduction was slow and reached its minimum after 4 weeks of treatment ( Figure S7A ). In line with the reduction of Csf1, antibiotic treatment also resulted in a decrease of MM numbers ( Figures 7G, S7B , and S7C) with similar kinetics ( Figure S7B ). No reduction in the numbers of mucosal macrophages was observed during the course of antibiotic treatment (data not shown). Additionally, the numbers of Gr1 hi blood monocytes that give rise to both mucosal macrophages (Bogunovic et al., 2009) and MMs (M.B., unpublished data) were not affected, thus excluding an effect on myeloid cell development in the BM ( Figure S7D ). Microbiota-associated factors that influence GI motility include constituents of nutriment breakdown, byproducts of microbial metabolism, and microbial cellular components such as LPS (Reigstad and Kashyap, 2013) . While cecum enlargement was an early sign of antibiotic treatment, cecum size continued to increase over the course of treatment (Figure S7E) , implying that various microbiota-associated factors contribute to antibiotic-induced dysmotility with different kinetics. The kinetics of reduction in Csf1 expression and MM numbers was delayed as compared with the reduction of bacteria in the gut lumen during the antibiotic treatment (Figure S7F ), suggesting that a decrease in serum LPS after prolonged antibiotic treatment (Anitha et al., 2012 ) might be responsible for those changes. To test this, we supplemented mice with LPS in drinking water as described previously (Rakoff-Nahoum et al., 2004) while maintaining them on antibiotics. Consistent with the in vitro data and our hypothesis, LPS supplementation prevented the reduction of Csf1 expression and MM numbers ( Figures 7F, 7G , and S7C). LPS supplementation also partially improved GI transit time ( Figure 7H ) and reduced cecum size ( Figure S7G ).
Next, we asked whether the MM-neuronal crosstalk is reversible. Antibiotic-treated mice were reconstituted with microbiota following fecal transfer (FT) from untreated control mice. Repopulation of luminal bacteria to nearly normal levels ( Figure S7H ) was able to restore Csf1 expression ( Figure 7F ) and MM numbers ( Figure 7G ) in the gut, and correct dysmotility ( Figure 7I ) and cecum size ( Figure S7I ).
Taken together, these results demonstrate that the function of both components of macrophage-neuronal crosstalk can be reversibly modified by luminal commensals. (legend continued on next page)
DISCUSSION
MMs are thought to regulate GI motility during inflammation through secretion of inflammatory cytokines and the recruitment of inflammatory cells, which further accelerate the inflammatory process (Boeckxstaens and de Jonge, 2009; Mikkelsen, 2010; Wehner et al., 2007) . This mechanism, however, has not been proven directly to occur. Our data demonstrate that MMs regulate GI motility even when the bowel is not inflamed, and MMs do so through production of the soluble growth factor BMP2. Whether BMP2 remains a key factor in regulating GI motility during inflammation remains to be determined. Our study suggests that MM-derived BMP2 regulates the functional activity of neurons, transcending the known role of this growth factor in neuronal development (Chalazonitis et al., 2004 (Chalazonitis et al., , 2008 . While MMs or MM-specific BMP2 may contribute to ENS development, as suggested by our data from Csf1 op/op mice, the mechanisms by which BMPs affect homeostasis or the function(s) of differentiated enteric neurons are not clear. Studies of BMPR signaling in motoneurons at the neuromuscular junction of developing Drosophila larvae suggest that BMPR signaling regulates the microtubule stability of axons, fast axonal transport, and synaptic growth and stability (Aberle et al., 2002; Eaton and Davis, 2005; Eaton et al., 2002; Nahm et al., 2013; Wang et al., 2007) . More recently, BMPs have been demonstrated to inhibit constitutive electrical activity in differentiating neurons of the developing Xenopus spinal cord (Swapna and Borodinsky, 2012) . We postulate that BMPs may exert similar effects on adult neurons. It is also possible that additional MMderived factors can affect the function of enteric neurons. A recent study revealed the role of the resident macrophages of the CNS, the microglia, in promoting learning-dependent synapse formation by providing brain-derived neurotrophic factor (BDNF) to neurons (Parkhurst et al., 2013) . Likewise, macrophage populations at other sites may participate in regulating the physiology of organs through mechanisms similar to those observed in the gut and the brain.
The reduction of BMP2 expression in mice after antibiotic treatment implies that MMs are sensitive to changes in the luminal environment, but the mechanism of this sensitivity remains unknown. Interestingly, prolonged Helicobacter hepaticus infection has been shown to dramatically affect MM activation and behavior even though Helicobacter never crosses the epithelial barrier of the gut (Hoffman and Fleming, 2010) . It appears plausible that alterations of MMs occur through a combination of downstream immune and neuronal surveillance in the mucosa, including signals provided by Toll-like-receptor-positive enteroendocrine cells (Bogunovic et al., 2007) . It is also possible that MMs recognize commensal components directly by sensing systemic LPS found in the serum of normal mice (Anitha et al., 2012; Uramatsu et al., 2010) .
Chronic disruption of normal peristaltic activity is a characteristic symptom of functional GI disorders such as irritable bowel syndrome (IBS). In IBS patients, dysmotility-related symptoms are often accompanied by symptoms associated with visceral hypersensitivity, an exaggerated perceptual response to peripheral stimuli that could result from altered processing of visceral neuronal afferent signals (Faure et al., 2007a) . Histological analysis of full-thickness intestinal biopsies from IBS patients revealed signs of degenerative or inflammatory neuropathy (Lindberg et al., 2009; Tö rnblom et al., 2002) . Changes in the microbial environment, such as a preceding bacterial GI infection and SB bacterial overgrowth, have been proposed to be causes of IBS (Peralta et al., 2009; Pimentel et al., 2000 Pimentel et al., , 2002 Pimentel et al., , 2003 ). An improved understanding of the interplay among enteric neurons, MMs, and luminal signals may thus provide new therapeutic strategies for the treatment and/or prevention of IBS.
EXPERIMENTAL PROCEDURES Mice
All mice were housed in a specific pathogen-free environment at the Mount Sinai School of Medicine and Penn State College of Medicine and were used in accordance with protocols approved by the Institutional Animal Care and Utilization Committees. A list of the mouse strains used is provided in the Extended Experimental Procedures.
MP depletion was achieved by single i.p. injection of 37.5 mg/g aCSF1R mAb (clone AFS98; Sudo et al., 1995) purified from hybridomas as described previously (Hashimoto et al., 2011a) .
Cell Isolation, Flow Cytometry, and Cell Sorting Single-cell suspensions of intestinal muscularis externa or entire bowel were prepared, analyzed, and purified as described previously (Bogunovic et al., 2009 ).
Immunofluorescence Separated intestinal muscularis externa or cultured enteric neurons were stained according to a previously described protocol (Bogunovic et al., 2009 ) with some modifications and using commercial reagents described in the Extended Experimental Procedures.
Gene Expression Microarray
A murine gene expression microarray was performed and normalized by the Immgen Project (http://www.immgen.org) as described previously (Miller et al., 2012) . The gene-expression profile of MMs is posted on www. immgen.org under ''Small intestine serosal macrophages,'' abbreviated as MF.CD11cloSer.SI.
(F) Rms of colonic contraction recordings normalized to baseline (%) at stretch intervals of 1.5-3.5 mm; 3 mm colonic rings were obtained from WT mice treated with the BMPR inhibitor dorsomorphin or control vehicle (mean ± SEM). (G) WT mice were injected i.p. with isotype IgG (top) or aCSF1R mAb (bottom) and analyzed 2 days later. Panels show ex vivo recordings of stretch-induced contractions of colonic rings from these mice before and after adding 1, 5, or 10 ng of human recombinant BMP2 or control vehicle (performed at 2.75 mm ''optimal'' stretch distance). (H) Rms of the 10 min recordings described in (G) (bottom: aCSF1R mAb-treated mice) before and after adding 5 ng of BMP2. (I) Rms normalized to baseline (%) of recordings described in (G) (bottom: aCSF1R mAb-treated mice) after adding BMP2 (1, 5, or 10 ng) or control vehicle (mean ± SEM). Baseline here is the recording at the same stretch distance (2.75 mm) prior to adding BMP2 or control vehicle. (J) Colonic transit time measured by bead expulsion assay in WT mice before they received aCSF1R mAb (day À1) and on days 3 and 4 after they received aCSF1R mAb; 18 and 3 hr before the last assessment (day 4), the mice received 1 mg of BMP2 i.p. (mean ± SEM). See also Figure S3 . Real-Time PCR Real-time PCR was performed as described previously (Bogunovic et al., 2009 ) with some modifications as explained in Extended Experimental Procedures. The data were normalized to b-actin. Each data dot on sorted primary cells was obtained by analyzing RNA from 50,000 cells purified from five to seven mice. Each data dot from cultured neurons was obtained by analyzing RNA from an independent primary neuronal culture.
Colonic Peristalsis Ex Vivo
The method used to measure colonic peristalsis ex vivo is described in the Extended Experimental Procedures. To block BMPR signaling, 13 mg/g (Helbing et al., 2011) of dorsomorphin (Sigma) in DMSO was injected i.p. 18 and 2 hr prior to analysis. In BMP2 ''rescue'' experiments the colonic rings were distended until 2.75 mm. A baseline recording of 40 min was taken, after which recombinant human BMP2 (R&D Systems) dissolved in 4 mM HCl was cumulatively added Figure S5 .
to the bath (1, 5, and 10 ng per 8 ml organ bath) followed by 10 min of recording between doses. The dose response to KCl was determined by distending the colonic rings until a baseline force of 0.5 mN was achieved. The rings were allowed to equilibrate for 2.5 hr, with hourly solution changes. Increasing concentrations of KCl (0, 10, 40, 80, 100, and 200 mM) were added to the bath and solution was changed after 5 min. Ratios were calculated as baseline force prior to KCl addition over maximal contractile force after KCl addition.
GI Motility
Colonic transit time was detected by bead expulsion assay (Li et al., 2006) . Gastric emptying, SB transit, and total intestinal transit time were measured as described previously (Li et al., 2011) . Control and experimental groups were age and sex matched. For in vivo ''rescue'' experiments, human recombinant BMP2 (Peprotech) was injected i.p. (50 ng/g of body weight) 18 and 3 hr prior to measuring colonic transit time.
Epithelial Permeability
Epithelial permeability studies were performed as described previously (Dahan et al., 2011) .
In Vitro Culture of Enteric Neurons
In vitro culture of enteric neurons was prepared from embryonic intestines from embryonic day 17 (E17) as described in Extended Experimental Procedures.
Antibiotic Treatment
For antibiotic treatment, a variation of a published protocol (Rakoff-Nahoum et al., 2004) was used. Six to 7-week-old female mice were given drinking water containing 1 g/l of ampicillin (Teknova), 1 g/l of streptomycin (GIBCO), 1 g/l of metronidazole (Sigma), and 1 g/l of vancomycin (Sigma) for 1-4 weeks. For LPS supplementation, mice were given 50 mg/ml of LPS from E. coli O111:B4 (Sigma) in drinking water (Rakoff-Nahoum et al., 2004) together with antibiotics for 4 weeks.
Fecal Transfer
Recipient mice were placed on antibiotic-free water 24 hr prior to FT. Intestinal contents from donor mice, prepared as described in Extended Experimental Procedures, were given to recipient mice by oral gavage. Donor mice were age matched, obtained from the same vendor, and maintained in the same facility as the recipients of FT. (E) Csf1 relative gene-expression levels in cultured primary enteric neurons measured by qPCR. Differentiated neurons were cultured with or without 10 ng/ml of LPS for 18 hr prior to analyses. FI, fold increase as compared with Csf1 levels in the intact muscularis (mean ± SEM). Each data point represents qPCR results obtained from an independent neuronal culture. (F) Csf1 relative gene-expression levels quantified by qPCR in LB muscularis from WT mice treated with antibiotics for 4 weeks (left), WT mice treated with antibiotics and 50 mg/ml LPS in drinking water for 4 weeks (middle), and WT mice 3 weeks after they received fecal transfer (FT) following a 4-week course of antibiotics (right). The data are compared with data for age-matched control mice that received only water. FI, fold increase as compared with average Csf1 levels in the control group that received water (mean ± SEM). (G) Absolute numbers of MMs quantified by FACS in LB from WT mice that received antibiotics (left), antibiotics with LPS (middle), and FT following antibiotic treatment (right) as in (F). The data are compared with data for age-matched control mice that received only water (mean ± SEM). (H) Total GI transit time in WT mice that received antibiotics and 50 mg/ml LPS with drinking water for 4 weeks and age-matched mice that received only antibiotics for 4 weeks (mean ± SEM). (I) Total GI transit time in WT mice 3 weeks after they received FT following a 4-week course of antibiotics and control mice that received water (mean ± SEM). See also Figures S6 and S7.
Bacterial 16S rDNA qPCR Bacterial 16S rDNA qPCR to quantify fecal bacterial DNA was performed as described in the Extended Experimental Procedures.
Statistical Analysis
Data are presented as mean ± SEM. The statistical significance of differences between group means was determined with the two-tailed unpaired or paired Student's t test and one-way ANOVA. Values of p < 0.05 (*), p < 0.005 (**), and p < 0.0005 (***) indicate statistical significance. 
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